2HE

Healthequity Inc

Healthcare · EUR · F

2HE

Price

€73.734

-1.73%

Cap

€7.17B

Earnings

30d Trend

+3.9%

2HE
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

37% annualised over 90 days

BRAIN47 SIGNAL

0
MODERATE
Risk Level65
Quality71
Momentum19
Technical61
Fundamentals61

Raw weighted: 51×Macro 0.99 (1%)=50

RISK

65/100
90d Volatility
36.5%High
ATR %
3.3%High daily moves
Max Drawdown (1Y)
-35.2%Volatile

QUALITY

71/100
ROE (avg)
10.2%Good
Piotroski F-Score
8/9Strong
Debt/Equity
0.45Low leverage
Margin Stability
CV 4.9%Very stable
Accruals
-7.2%Cash earnings
Interest Coverage
5.8xAdequate

MOMENTUM

19/100
12-1M Momentum
-21.5%Strong downtrend
6-1M Momentum
-25.0%Negative
1M Return
+11.1%Strong recent gains

TECHNICAL

61/100
RSI (14)
65.6Neutral
Price vs SMA200
+2.4%Bullish trend
MACD
+0.65Bullish momentum
Bollinger Band
111%Near upper band
SMA Cross
Golden CrossGolden Cross
Trend Quality (KER)
0.379Mixed

FUNDAMENTALS

61/100
EV/EBIT
24.7Fair
P/FCF
16.1Fair
P/S
5.6Fair
Shareholder Yield
4.1%Moderate

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months66
3-12 months51
1-5+ years57

Short-term opportunity — technical setup

BRAIN47'S ASSESSMENT

I rate Healthequity Inc at 50/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is quality at 71/100. I classify this as a income position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

+11.1%

3 MONTHS

+18.3%

12 MONTHS

-10.4%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Short-term opportunity — technical setup. Quality (71) and Technical (61) are the primary strengths. I note that momentum is the weakest area at 19/100 — this warrants monitoring. Historical volatility is moderate at 37%. I classify this as an income position — the 4.1% yield combined with the dividend profile makes it suitable for income generation.

incomeScore: 50/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.